209 related articles for article (PubMed ID: 16679090)
1. Effect of atorvastatin on the recurrence rates of atrial fibrillation after electrical cardioversion.
Ozaydin M; Varol E; Aslan SM; Kucuktepe Z; Dogan A; Ozturk M; Altinbas A
Am J Cardiol; 2006 May; 97(10):1490-3. PubMed ID: 16679090
[TBL] [Abstract][Full Text] [Related]
2. Atorvastatin given prior to electrical cardioversion does not affect the recurrence of atrial fibrillation in patients with persistent atrial fibrillation who are on antiarrhythmic therapy.
Demir K; Can I; Koc F; Vatankulu MA; Ayhan S; Akilli H; Aribas A; Alihanoglu Y; Altunkeser BB
Med Princ Pract; 2011; 20(5):464-9. PubMed ID: 21757938
[TBL] [Abstract][Full Text] [Related]
3. Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion.
Loricchio ML; Cianfrocca C; Pasceri V; Bianconi L; Auriti A; Calo L; Lamberti F; Castro A; Pandozi C; Palamara A; Santini M
Am J Cardiol; 2007 May; 99(10):1421-4. PubMed ID: 17493472
[TBL] [Abstract][Full Text] [Related]
4. Baseline apnoea/hypopnoea index and high-sensitivity C-reactive protein for the risk of recurrence of atrial fibrillation after successful electrical cardioversion: a predictive model based upon the multiple effects of significant variables.
Mazza A; Bendini MG; Cristofori M; Nardi S; Leggio M; De Cristofaro R; Giordano A; Cozzari L; Giordano G; Cappato R
Europace; 2009 Jul; 11(7):902-9. PubMed ID: 19443431
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin and persistent atrial fibrillation following cardioversion: a randomized placebo-controlled multicentre study.
Almroth H; Höglund N; Boman K; Englund A; Jensen S; Kjellman B; Tornvall P; Rosenqvist M
Eur Heart J; 2009 Apr; 30(7):827-33. PubMed ID: 19202157
[TBL] [Abstract][Full Text] [Related]
6. High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion.
Watanabe E; Arakawa T; Uchiyama T; Kodama I; Hishida H
Int J Cardiol; 2006 Apr; 108(3):346-53. PubMed ID: 15964643
[TBL] [Abstract][Full Text] [Related]
7. N-3 polyunsaturated fatty acids administration does not reduce the recurrence rates of atrial fibrillation and inflammation after electrical cardioversion: a prospective randomized study.
Ozaydın M; Erdoğan D; Tayyar S; Uysal BA; Doğan A; Içli A; Ozkan E; Varol E; Türker Y; Arslan A
Anadolu Kardiyol Derg; 2011 Jun; 11(4):305-9. PubMed ID: 21543294
[TBL] [Abstract][Full Text] [Related]
8. Statins and amiodarone improve freedom from recurrence of atrial fibrillation after successful cardioversion.
Naji F; Suran D; Kanic V; Vokac D; Sabovic M
Med Sci Monit; 2009 Sep; 15(9):CR494-8. PubMed ID: 19721402
[TBL] [Abstract][Full Text] [Related]
9. The predictive value of C-reactive protein on recurrence of atrial fibrillation after cardioversion with or without treatment with atorvastatin.
Höglund N; Andersson J; Almroth H; Tornvall P; Englund A; Rosenqvist M; Jensen SM; Boman K
Int J Cardiol; 2013 Sep; 167(5):2088-91. PubMed ID: 22704860
[TBL] [Abstract][Full Text] [Related]
10. Effects of rosuvastatin on asymmetric dimethylarginine levels and early atrial fibrillation recurrence after electrical cardioversion.
Xia W; Yin Z; Li J; Song Y; Qu X
Pacing Clin Electrophysiol; 2009 Dec; 32(12):1562-6. PubMed ID: 19793367
[TBL] [Abstract][Full Text] [Related]
11. The effect of sinus rhythm restoration on high-sensitivity C-reactive protein levels and their association with long-term atrial fibrillation recurrence after electrical cardioversion.
Celebi OO; Celebi S; Canbay A; Ergun G; Aydogdu S; Diker E
Cardiology; 2011; 118(3):168-74. PubMed ID: 21654170
[TBL] [Abstract][Full Text] [Related]
12. [Relationship between C-reactive protein level and early recurrence of atrial fibrillation after electrical cardioversion].
Zarauza J; Rodríguez Lera MJ; Fariñas Alvarez C; Hernando JP; Ceballos B; Gutiérrez B; Pérez J; Cuesta JM
Rev Esp Cardiol; 2006 Feb; 59(2):125-9. PubMed ID: 16540033
[TBL] [Abstract][Full Text] [Related]
13. Verapamil versus digoxin and acute versus routine serial cardioversion for the improvement of rhythm control for persistent atrial fibrillation.
Hemels ME; Van Noord T; Crijns HJ; Van Veldhuisen DJ; Veeger NJ; Bosker HA; Wiesfeld AC; Van den Berg MP; Ranchor AV; Van Gelder IC
J Am Coll Cardiol; 2006 Sep; 48(5):1001-9. PubMed ID: 16949494
[TBL] [Abstract][Full Text] [Related]
14. Long-term prognostic value of baseline C-reactive protein in predicting recurrence of atrial fibrillation after electrical cardioversion.
Korantzopoulos P; Kalantzi K; Siogas K; Goudevenos JA
Pacing Clin Electrophysiol; 2008 Oct; 31(10):1272-6. PubMed ID: 18811807
[TBL] [Abstract][Full Text] [Related]
15. Atorvastatin prevents atrial fibrillation in patients with bradyarrhythmias and implantation of an atrial-based or dual-chamber pacemaker: a prospective randomized trial.
Tsai CT; Lai LP; Hwang JJ; Wang YC; Chiang FT; Lin JL
Am Heart J; 2008 Jul; 156(1):65-70. PubMed ID: 18585498
[TBL] [Abstract][Full Text] [Related]
16. The role of the post-cardioversion time course of hs-CRP levels in clarifying the relationship between inflammation and persistence of atrial fibrillation.
Kallergis EM; Manios EG; Kanoupakis EM; Mavrakis HE; Kolyvaki SG; Lyrarakis GM; Chlouverakis GI; Vardas PE
Heart; 2008 Feb; 94(2):200-4. PubMed ID: 17575330
[TBL] [Abstract][Full Text] [Related]
17. Pre-ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation: the potential role of inflammation.
Letsas KP; Weber R; Bürkle G; Mihas CC; Minners J; Kalusche D; Arentz T
Europace; 2009 Feb; 11(2):158-63. PubMed ID: 19010799
[TBL] [Abstract][Full Text] [Related]
18. High sensitivity C-reactive protein: a novel predictor for recurrence of atrial fibrillation after successful cardioversion.
Malouf JF; Kanagala R; Al Atawi FO; Rosales AG; Davison DE; Murali NS; Tsang TS; Chandrasekaran K; Ammash NM; Friedman PA; Somers VK
J Am Coll Cardiol; 2005 Oct; 46(7):1284-7. PubMed ID: 16198844
[TBL] [Abstract][Full Text] [Related]
19. Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome.
Boriani G; Diemberger I; Biffi M; Domenichini G; Martignani C; Valzania C; Branzi A
Int J Clin Pract; 2007 May; 61(5):748-56. PubMed ID: 17493088
[TBL] [Abstract][Full Text] [Related]
20. Enhancing electrical cardioversion and preventing immediate reinitiation of hemodynamically deleterious atrial fibrillation with class III drug pretreatment.
Hayashi M; Tanaka K; Kato T; Morita N; Sato N; Yasutake M; Kobayashi Y; Takano T
J Cardiovasc Electrophysiol; 2005 Jul; 16(7):740-7. PubMed ID: 16050832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
